Investigations on inhibitors of hedgehog signal pathway: A quantitative structure-activity relationship study

International Journal of Molecular Sciences

Volumn 12, Issue 5, 2011, Pages 3018-3033

  Zhu, Ruixin ^a   Liu, Qi ^a   Tang, Jian ^b   Li, Huiliang ^b   Cao, Zhiwei ^a  

^a TONGJI UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cyclopamine; Hedgehog signal pathway; Inhibitor; QSAR

Indexed keywords

CYCLOPAMINE; SONIC HEDGEHOG PROTEIN; VERATRUM ALKALOID;

ARTICLE; BAYESIAN LEARNING; CANCER CELL CULTURE; CONTROLLED STUDY; DEMETHYLATION; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; HYDROXYLATION; METHYLATION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; SUPPORT VECTOR MACHINE; ANTAGONISTS AND INHIBITORS; BAYES THEOREM; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; HUMAN; REGRESSION ANALYSIS;

ERINACEIDAE;

BAYES THEOREM; CELL LINE; COMPUTER SIMULATION; HEDGEHOG PROTEINS; HUMANS; MODELS, MOLECULAR; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; REGRESSION ANALYSIS; SIGNAL TRANSDUCTION; VERATRUM ALKALOIDS;

EID: 79957828077     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms12053018     Document Type: Article

References (47)

1. Ingham, P.W.; McMahon, A.P. Hedgehog signaling in animal development: Paradigms and principles. Gene. Dev. 2001, 15, 3059-3087.
2. Oro, A.E.; Higgins, K.M.; Hu, Z.; Bonifas, J.M.; Epstein, E.H., Jr.; Scott, M.P. Basal cell carcinomas in mice overexpressing sonic hedgehog. Science 1997, 276, 817-821.
3. Kinzler, K.W.; Bigner, S.H.; Bigner, D.D.; Trent, J.M.; Law, M.L.; O'Brien, S.J.; Wong, A.J.; Vogelstein, B. Identification of an amplified, highly expressed gene in a human glioma. Science 1987, 236, 70-73.
4. Dahmane, N.; Lee, J.; Robins, P.; Heller, P.; Ruizi Altaba, A. Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours. Nature 1997, 389, 876-881.
5. Grachtchouk, M.; Mo, R.; Yu, S.; Zhang, X.; Sasaki, H.; Hui, C.C.; Dlugosz, A.A. Basal cell carcinomas in mice overexpressing Gli2 in skin. Nat. Genet. 2000, 24, 216-217.
6. Reifenberger, J.; Wolter, M.; Weber, R.G.; Megahed, M.; Ruzicka, T.; Lichter, P.; Reifenberger, G. Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res. 1998, 58, 1798-1803.
7. Dahmane, N.; Sanchez, P.; Gitton, Y.; Palma, V.; Sun, T.; Beyna, M.; Weiner, H.; Ruizi Altaba, A. The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis. Development 2001, 128, 5201-5212.
8. Chen, J.K.; Taipale, J.; Young, K.E.; Maiti, T.; Beachy, P.A. Small molecule modulation of Smoothened activity. Proc. Nat. Acad. Sci. USA 2002, 99, 14071-14076.
9. Chen, J.K.; Taipale, J.; Cooper, M.K.; Beachy, P.A. Inhibition of hedgehog signaling by direct binding of cyclopamine to smoothened. Gene. Dev. 2002, 16, 2743-2748.
10. Beachy, P.; Porter, J. Hedgehog-derived polypeptides. U.S. Patent No. 6911528, 28 June 2005.
11. Taipale, J.; Chen, J.K.; Cooper, M.K.; Wang, B.; Mann, R.K.; Milenkovic, L.; Scott, M.P.; Beachy, P.A. Effects of oncogenic mutations in smoothened and patched can be reversed by cyclopamine. Nature 2000, 406, 1005-1009.
12. Giannis, A.; Heretsch, P.; Sarli, V.; Stossel, A. Synthesis of cyclopamine using a biomimetic and diastereoselective approach. Angew. Chem. Int. Ed. Engl. 2009, 48, 7911-7914.
13. Zhang, J.; Garrossian, M.; Gardner, D.; Garrossian, A.; Chang, Y.T.; Kim, Y.K.; Chang, C.W. Synthesis and anticancer activity studies of cyclopamine derivatives. Bioorg. Med. Chem. Lett. 2008, 18, 1359-1363.
14. Janardanannair, S.; Adams, J.; Ripka, A.S. Methods for preparation cyclopamine analogs and use thereof in treating cancers. U.S. Patent 7,407,967 B2, 5 August 2008.
15. Tang, J.; Li, H.L.; Shen, Y.H.; Jin, H.Z.; Yan, S.K.; Liu, R.H.; Zhang, W.D. Antitumor activity of extracts and compounds from the rhizomes of Veratrum dahuricum. Phytother. Res. 2008, 22, 1093-1096.
16. Tang, J.; Li, H.L.; Shen, Y.H.; Jin, H.Z.; Yan, S.K.; Liu, X.H.; Zeng, H.W.; Liu, R.H.; Tan, Y.X.; Zhang, W.D. Antitumor and antiplatelet activity of alkaloids from Veratrum dahuricum. Phytother. Res. 2010, 24, 821-826.
17. Xu, J.; Stevenson, J. Drug-like index: A new approach to measure drug-like compounds and their diversity. J. Chem. Inf. Comput. Sci. 2000, 40, 1177-1187.
18. Labute, P. A widely applicable set of descriptors. J. Mol. Graph. Model. 2000, 18, 464-477.
19. Molecular Operation Eenvironment, version 2008.10; Chemical Computing Group Inc.: Montreal, Quebec, Canada, 2008.
20. Discovery Studio, version 2.0; Accelrys Software Inc.: San Diego, CA, USA, 2007.
21. Sybyl, version 6.8.; Tripos Inc.: St Louis, MO, USA, 2001.
22. Balabin, R.M.; Lomakina, E.I. Neural network approach to quantum-chemistry data: Accurate prediction of density functional theory energies. J. Chem. Phys. 2009, 131, 74104.
23. Gelman, A.; Carlin, J.B.; Stern, H.S.; Rubin, D.B. Bayesian Data Analysis, 2nd ed.; Chapman and Hall/CRC: Boca Raton, FL, USA, 2003.
24. Ho, T.K. A data complexity analysis of comparative advantages of decision forest constructors. Pattern Anal. Appl. 2002, 5, 102-112.
25. Cortes, C.; Vapnik, V. Support-vector networks. Mach. Learn. 1995, 20, 273-297.
26. Patra, J.C.; Singh, O. Artificial neural networks-based approach to design ARIs using QSAR for diabetes mellitus. J. Comput. Chem. 2009, 30, 2494-2508.
27. Bucinski, A.; Socha, A.; Wnuk, M.; Baczek, T.; Nowaczyk, A.; Krysinski, J.; Gorynski, K.; Koba, M. Artificial neural networks in prediction of antifungal activity of a series of pyridine derivatives against Candida albicans. J. Microbiol. Meth. 2009, 76, 25-29.
28. Kahn, I.; Sild, S.; Maran, U. Modeling the toxicity of chemicals to Tetrahymena pyriformis using heuristic multilinear regression and heuristic back-propagation neural networks. J. Chem. Inf. Model. 2007, 47, 2271-2279.
29. Vijayan, R.S.; Bera, I.; Prabu, M.; Saha, S.; Ghoshal, N. Combinatorial library enumeration and lead hopping using comparative interaction fingerprint analysis and classical 2D QSAR methods for seeking novel GABA(A) alpha(3) modulators. J. Chem. Inf. Model. 2009, 49, 2498-2511.
30. Tang, H.; Wang, X.S.; Huang, X.P.; Roth, B.L.; Butler, K.V.; Kozikowski, A.P.; Jung, M.; Tropsha, A. Novel inhibitors of human histone deacetylase (HDAC) identified by QSAR modeling of known inhibitors, virtual screening, and experimental validation. J. Chem. Inf. Model. 2009, 49, 461-476.
31. Burden, F.R.; Winkler, D.A. Optimal sparse descriptor selection for QSAR using bayesian methods. QSAR Comb. Sci. 2009, 28, 645-653.
32. Abdoa, A.; Salima, N. Similarity-based virtual screening using bayesian inference network: Enhanced search using 2D fingerprints and multiple reference structures. QSAR Comb. Sci. 2009, 28, 654-663.
33. Li, Y.; Wang, Y.; Ding, J.; Wang, Y.; Chang, Y.Q.; Zhang, S.W. In silico prediction of androgenic and nonandrogenic compounds using random forest. QSAR Comb. Sci. 2009, 28, 396-405.
34. Zhu, J.X.; Lu, W.C.; Liu, L.; Gu, T.H.; Niu, B. Classification of Src Kinase inhibitors based on support vector machine. QSAR Comb. Sci. 2009, 28, 719-727.
35. Polishchuk, P.G.; Muratov, E.N.; Artemenko, A.G.; Kolumbin, O.G.; Muratov, N.N.; Kuz'min, V.E. Application of random forest approach to QSAR prediction of aquatic toxicity. J. Chem. Inf. Model. 2009, 49, 2481-2488.
36. Sun, M.; Zheng, Y.G.; Wei, H.T.; Chen, J.Q.; Cai, J.; Ji, M. Enhanced replacement method-based quantitative structure-activity relationship modeling and support vector machine classification of 4-Anilino-3-quinolinecarbonitriles as Src Kinase inhibitors. QSAR Comb. Sci. 2009, 28, 312-324.
37. Darnag, R.; Schmitzer, A.; Belmiloud, Y.; Villemin, D.; Jarid, A.; Chait, A.; Seyagh, M.; Cherqaoui, D. QSAR studies of HEPT derivatives using support vector machines. QSAR Comb. Sci. 2009, 28, 709-718.
38. Rao, H.B.; Yang, G.B.; Tan, N.X.; Li, P.; Li, Z.R.; Li, X.Y. Prediction of HIV-1 Protease inhibitors using machine learning approaches. QSAR Comb. Sci. 2009, 28, 1346-1357.
39. Goodarzi, M.; Freitas, M.P.; Jensen, R. Feature selection and linear/nonlinear regression methods for the accurate prediction of glycogen synthase kinase-3beta inhibitory activities. J. Chem. Inf. Model. 2009, 49, 824-832.
40. Watkins, D.N.; Berman, D.M.; Burkholder, S.G.; Wang, B.; Beachy, P.A.; Baylin, S.B. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 2003, 422, 313-317.
41. Thayer, S.P.; di Magliano, M.P.; Heiser, P.W.; Nielsen, C.M.; Roberts, D.J.; Lauwers, G.Y.; Qi, Y.P.; Gysin, S.; Fernandez-del Castillo, C.; Yajnik, V.; et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003, 425, 851-856.
42. Sasai, K.; Romer, J.T.; Lee, Y.; Finkelstein, D.; Fuller, C.; McKinnon, P.J.; Curran, T. Shh pathway activity is down-regulated in cultured medulloblastoma cells: Implications for preclinical studies. Cancer Res. 2006, 66, 4215-4222.
43. Helland, I.S. On the structure of partial least squares regression. Comm. Stat. Simulat. Comput. 1988, 17, 581-607.
44. Gelaldi, P.; Kowalski, R. Partial least squares regression: A tutorial. Anal. Chim. Acta 1986, 185, 1-17.
45. Drucker, H.; Burges, C.J.C.; Kaufman, L.; Smola, A.J.; Vapnik, V. Support Vector Regression Machines; MIT Press: Cambridge, MA, USA, 1996; pp. 155-161.
46. Watanabe, N.; Adachi, H.; Takase, Y.; Ozaki, H.; Matsukura, M.; Miyazaki, K.; Ishibashi, K.; Ishihara, H.; Kodama, K.; Nishino, M.; et al. 4-(3-Chloro-4-methoxybenzyl)aminophthalazines: Synthesis and inhibitory activity toward phosphodiesterase 5. J. Med. Chem. 2000, 43, 2523-2529.
47. Schuffenhauer, A.; Ertl, P.; Roggo, S.; Wetzel, S.; Koch, M.A.; Waldmann, H. The scaffold tree-visualization of the scaffold universe by hierarchical scaffold classification. J. Chem. Inf. Model. 2007, 47, 47-58.